Company intelligence / Profile preview

OMEC.AI

Rehovot, Israel

Ownership: Private
Development stage: Other

Overview

OMEC.AI is an AI-driven platform company that analyzes multi-omics and other preclinical data to identify hidden safety and efficacy risks and to assess the clinical trial readiness of drug candidates, aiming to improve success rates in human trials.

Industry: Drug Discovery Services

Partnerships

PfizerAstraZenecaMerck (MSD)Teva Pharmaceuticals (via AION Labs consortium)Amazon Web Services (AWS)Israel Innovation Authority (funding/innovation lab program)

Beyond the preview

Go deeper on OMEC.AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMEC.AI.

Explore the full profile